Clinical trials
Overweight trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 8 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 20 |
| 2024 | 9 |
| 2025 | 22 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 72 |
| Recruiting | 33 |
| Active, not recruiting | 16 |
| Unknown status | 15 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 13 |
| Eli Lilly and Company | 12 |
| AstraZeneca | 7 |
| Loughborough University | 5 |
| University of Oxford | 5 |
| Amgen | 4 |
| Imperial College London | 4 |
| University of Glasgow | 4 |
| University of Leeds | 4 |
| University of Nottingham | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 144 |
| Obesity | 129 |
| Diabetes Mellitus, Type 2 | 16 |
| Weight Loss | 8 |
| Body Weight | 7 |
| Diabetes Mellitus | 6 |
| Metabolic Syndrome | 6 |
| Cardiovascular Diseases | 5 |
| Nutrition Disorders | 4 |
| Prediabetic State | 4 |
Trials
Showing 51 to 75 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.